Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × Desflurane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Pituitary Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Myofibroma 1 Melanoma 1 Liver Functions Tests 1 Gallbladder Neoplasms 1 Colonic Neoplasms 1 Cholecystitis 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Brain Edema 1 Adenocarcinoma 1

Interventions

Iodine-131 18 lenvatinib 15 trametinib 10 Sorafenib 10 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Thyroidectomy 9 vandetanib 8 dabrafenib 8 Thyroxine 8 Thyrotropin Alfa 8 Surgical Procedures, Operative 8 selpercatinib 7 Paclitaxel 7 anlotinib 6 Sunitinib 6 pazopanib 5 cabozantinib 5 Triiodothyronine 5 Saline Solution 5 Nivolumab 5 Fluorodeoxyglucose F18 5 Everolimus 5 Biopsy, Fine-Needle 5 Vemurafenib 4 Radiofrequency Ablation 4 Docetaxel 4 Dexmedetomidine 4 Cyclophosphamide 4 Biopsy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02412150 2020-11-27

Effect of Dexmedetomidine After Thyroidectomy

Chosun University Hospital

Phase NA Completed

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡